Revolution Medicines Announces Planned Leadership Transition for Steve Kelsey, M.D.

Go back to Revolution Medicines Announces Planned Leadership Transition for Steve Kelsey, M.D.
(NASDAQ: RVMD) Delayed: 190.95 -5.99 (3.04%)
Previous Close $196.94    52 Week High
Open $197.00    52 Week Low
Day High $197.10    P/E N/A 
Day Low $188.18    EPS
Volume 5,939,946